Ossium Health is a bioengineering company that develops stem cell therapies using a proprietary organ donor bone marrow banking platform. They focus on treating diseases of the blood and immune systems. Their services include cell therapy development and deployment, working closely with healthcare providers and life science companies. The target audience includes patients with blood and immune disorders, as well as healthcare organizations. Ossium's unique selling proposition is its innovative approach to leveraging deceased donor transplants for cell therapies, offering a new paradigm in this field[1][2][3].